Company Data
Spyre Therapeutics Inc.
Ticker
SYRE
Current Price
$79.9 -0.25%
Market Cap
$8.3B
Price Target
Refer to Report
Volume
1.3M
52wk Range
$21.01 - $110.175
Overview
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.